TLR-activated plasmacytoid dendritic cells inhibit breast cancer cell growth in vitro and in vivo.
about
Disease-Associated Plasmacytoid Dendritic Cells.Transcriptome and proteome profiling reveals stress-induced expression signatures of imiquimod-treated Tasmanian devil facial tumor disease (DFTD) cells.Recent advances in CD8+ regulatory T cell research.Recent advances in understanding dendritic cell development, classification, and phenotype
P2860
TLR-activated plasmacytoid dendritic cells inhibit breast cancer cell growth in vitro and in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TLR-activated plasmacytoid den ...... l growth in vitro and in vivo.
@en
TLR-activated plasmacytoid den ...... l growth in vitro and in vivo.
@nl
type
label
TLR-activated plasmacytoid den ...... l growth in vitro and in vivo.
@en
TLR-activated plasmacytoid den ...... l growth in vitro and in vivo.
@nl
prefLabel
TLR-activated plasmacytoid den ...... l growth in vitro and in vivo.
@en
TLR-activated plasmacytoid den ...... l growth in vitro and in vivo.
@nl
P2093
P2860
P356
P1433
P1476
TLR-activated plasmacytoid den ...... l growth in vitro and in vivo.
@en
P2093
Jingtao Chen
Mingyou Zhang
Yong-Jun Liu
P2860
P304
11708-11718
P356
10.18632/ONCOTARGET.14315
P407
P577
2016-12-28T00:00:00Z